Loading…
Kidney transplantation in sensitized recipients; a single center experience
A successful transplantation, across a positive crossmatch barrier, is one of the most persistent long-standing problems in the field of kidney transplant medicine. The aim of this study was to describe seven consecutive living renal transplantations in recipients with positive crossmatch for donors...
Saved in:
Published in: | Journal of Korean medical science 2009, 24(0), , pp.143-147 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173 |
---|---|
cites | cdi_FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173 |
container_end_page | S147 |
container_issue | Suppl 1 |
container_start_page | S143 |
container_title | Journal of Korean medical science |
container_volume | 24 Suppl |
creator | Kim, Sun Moon Lee, Chungsik Lee, Jung Pyo Kim, Eun Man Ha, Jongwon Kim, Sang Joon Park, Myoung Hee Ahn, Curie Kim, Yon Su |
description | A successful transplantation, across a positive crossmatch barrier, is one of the most persistent long-standing problems in the field of kidney transplant medicine. The aim of this study was to describe seven consecutive living renal transplantations in recipients with positive crossmatch for donors or positive for donor specific antibodies (DSAs). A preconditioning regimen including plasmapheresis and intravenous immunoglobulin was delivered three times a week until the crossmatch and/or DSAs became negative. Mycophenolate mofetil and tacrolimus were started two days before the plasmapheresis. The protocol was modified to include administration of anti-CD 20 antibody (rituximab, 375 mg/m(2)) from the patient number 3 through the patient number 7. All seven patients achieved negative conversion of the crossmatch or DSAs, and the kidney transplantations were successfully performed in all cases. Acute cellular rejection occurred in two patients, which were subclinical and controlled with high dose steroid treatment. Antibody-mediated rejection occurred in one patient, which was easily reversed with plasmapheresis. All recipients attained normal graft function during the 7-24 months of follow up. Our study suggests that sensitized patients can be transplanted successfully with desensitization pretreatment. |
doi_str_mv | 10.3346/jkms.2009.24.S1.S143 |
format | article |
fullrecord | <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_574478</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66890969</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173</originalsourceid><addsrcrecordid>eNpVkV9LHDEUxYO0VGv7DaTMU_Fltvlzk0kQCiKtikKh2ueQzdyxcWczYzJbaj-9GXexLQRuwj3n3Et-hBwxuhAC1Kf71TovOKVmwWFxw8oBsUcOmDS6VkI2r8qdMlZrI2CfvM35nlIuJRdvyD4zzIAEOCBXV6GN-FhNycU89i5ObgpDrEKsMsYcpvAH2yqhD2PAOOWTylU5xLseK1_emCr8PWIqPY_vyOvO9Rnf7-oh-fH1y-3ZRX397fzy7PS69iDMVDtntJaNhGXDQSBA67STbUu5k6ipN52nQisluGup0pQB0E45xKU0rWaNOCTH29yYOrvywQ4uPNe7wa6SPf1-e2llA9DoIv28lY6b5RrbeeXkejumsHbp8dn4fyeGnyXml-VKCE5lCfi4C0jDwwbzZNche-zLT-GwyVYpbahRpghhK_RpyDlh9zKEUTsDszMwOwOzHOwNszOwYvvw74J_TTtC4gmVxpSL</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66890969</pqid></control><display><type>article</type><title>Kidney transplantation in sensitized recipients; a single center experience</title><source>PubMed Central (Open Access)</source><creator>Kim, Sun Moon ; Lee, Chungsik ; Lee, Jung Pyo ; Kim, Eun Man ; Ha, Jongwon ; Kim, Sang Joon ; Park, Myoung Hee ; Ahn, Curie ; Kim, Yon Su</creator><creatorcontrib>Kim, Sun Moon ; Lee, Chungsik ; Lee, Jung Pyo ; Kim, Eun Man ; Ha, Jongwon ; Kim, Sang Joon ; Park, Myoung Hee ; Ahn, Curie ; Kim, Yon Su</creatorcontrib><description>A successful transplantation, across a positive crossmatch barrier, is one of the most persistent long-standing problems in the field of kidney transplant medicine. The aim of this study was to describe seven consecutive living renal transplantations in recipients with positive crossmatch for donors or positive for donor specific antibodies (DSAs). A preconditioning regimen including plasmapheresis and intravenous immunoglobulin was delivered three times a week until the crossmatch and/or DSAs became negative. Mycophenolate mofetil and tacrolimus were started two days before the plasmapheresis. The protocol was modified to include administration of anti-CD 20 antibody (rituximab, 375 mg/m(2)) from the patient number 3 through the patient number 7. All seven patients achieved negative conversion of the crossmatch or DSAs, and the kidney transplantations were successfully performed in all cases. Acute cellular rejection occurred in two patients, which were subclinical and controlled with high dose steroid treatment. Antibody-mediated rejection occurred in one patient, which was easily reversed with plasmapheresis. All recipients attained normal graft function during the 7-24 months of follow up. Our study suggests that sensitized patients can be transplanted successfully with desensitization pretreatment.</description><identifier>ISSN: 1011-8934</identifier><identifier>EISSN: 1598-6357</identifier><identifier>DOI: 10.3346/jkms.2009.24.S1.S143</identifier><identifier>PMID: 19194544</identifier><language>eng</language><publisher>Korea (South): The Korean Academy of Medical Sciences</publisher><subject>Adult ; Antibodies, Monoclonal - pharmacology ; Antibodies, Monoclonal, Murine-Derived ; Antigens, CD20 - biosynthesis ; Biopsy ; Female ; Graft Rejection ; Graft Survival ; Histocompatibility Testing - methods ; Humans ; Immunoglobulins - chemistry ; Kidney Transplantation - methods ; Male ; Middle Aged ; Original ; Plasmapheresis ; Rituximab ; Transplantation Conditioning ; 의학일반</subject><ispartof>Journal of Korean Medical Science, 2009, 24(0), , pp.143-147</ispartof><rights>Copyright © 2009 The Korean Academy of Medical Sciences 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173</citedby><cites>FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633205/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633205/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,4011,27905,27906,27907,53773,53775</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19194544$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001315820$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Sun Moon</creatorcontrib><creatorcontrib>Lee, Chungsik</creatorcontrib><creatorcontrib>Lee, Jung Pyo</creatorcontrib><creatorcontrib>Kim, Eun Man</creatorcontrib><creatorcontrib>Ha, Jongwon</creatorcontrib><creatorcontrib>Kim, Sang Joon</creatorcontrib><creatorcontrib>Park, Myoung Hee</creatorcontrib><creatorcontrib>Ahn, Curie</creatorcontrib><creatorcontrib>Kim, Yon Su</creatorcontrib><title>Kidney transplantation in sensitized recipients; a single center experience</title><title>Journal of Korean medical science</title><addtitle>J Korean Med Sci</addtitle><description>A successful transplantation, across a positive crossmatch barrier, is one of the most persistent long-standing problems in the field of kidney transplant medicine. The aim of this study was to describe seven consecutive living renal transplantations in recipients with positive crossmatch for donors or positive for donor specific antibodies (DSAs). A preconditioning regimen including plasmapheresis and intravenous immunoglobulin was delivered three times a week until the crossmatch and/or DSAs became negative. Mycophenolate mofetil and tacrolimus were started two days before the plasmapheresis. The protocol was modified to include administration of anti-CD 20 antibody (rituximab, 375 mg/m(2)) from the patient number 3 through the patient number 7. All seven patients achieved negative conversion of the crossmatch or DSAs, and the kidney transplantations were successfully performed in all cases. Acute cellular rejection occurred in two patients, which were subclinical and controlled with high dose steroid treatment. Antibody-mediated rejection occurred in one patient, which was easily reversed with plasmapheresis. All recipients attained normal graft function during the 7-24 months of follow up. Our study suggests that sensitized patients can be transplanted successfully with desensitization pretreatment.</description><subject>Adult</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Antibodies, Monoclonal, Murine-Derived</subject><subject>Antigens, CD20 - biosynthesis</subject><subject>Biopsy</subject><subject>Female</subject><subject>Graft Rejection</subject><subject>Graft Survival</subject><subject>Histocompatibility Testing - methods</subject><subject>Humans</subject><subject>Immunoglobulins - chemistry</subject><subject>Kidney Transplantation - methods</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Plasmapheresis</subject><subject>Rituximab</subject><subject>Transplantation Conditioning</subject><subject>의학일반</subject><issn>1011-8934</issn><issn>1598-6357</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNpVkV9LHDEUxYO0VGv7DaTMU_Fltvlzk0kQCiKtikKh2ueQzdyxcWczYzJbaj-9GXexLQRuwj3n3Et-hBwxuhAC1Kf71TovOKVmwWFxw8oBsUcOmDS6VkI2r8qdMlZrI2CfvM35nlIuJRdvyD4zzIAEOCBXV6GN-FhNycU89i5ObgpDrEKsMsYcpvAH2yqhD2PAOOWTylU5xLseK1_emCr8PWIqPY_vyOvO9Rnf7-oh-fH1y-3ZRX397fzy7PS69iDMVDtntJaNhGXDQSBA67STbUu5k6ipN52nQisluGup0pQB0E45xKU0rWaNOCTH29yYOrvywQ4uPNe7wa6SPf1-e2llA9DoIv28lY6b5RrbeeXkejumsHbp8dn4fyeGnyXml-VKCE5lCfi4C0jDwwbzZNche-zLT-GwyVYpbahRpghhK_RpyDlh9zKEUTsDszMwOwOzHOwNszOwYvvw74J_TTtC4gmVxpSL</recordid><startdate>200901</startdate><enddate>200901</enddate><creator>Kim, Sun Moon</creator><creator>Lee, Chungsik</creator><creator>Lee, Jung Pyo</creator><creator>Kim, Eun Man</creator><creator>Ha, Jongwon</creator><creator>Kim, Sang Joon</creator><creator>Park, Myoung Hee</creator><creator>Ahn, Curie</creator><creator>Kim, Yon Su</creator><general>The Korean Academy of Medical Sciences</general><general>대한의학회</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope></search><sort><creationdate>200901</creationdate><title>Kidney transplantation in sensitized recipients; a single center experience</title><author>Kim, Sun Moon ; Lee, Chungsik ; Lee, Jung Pyo ; Kim, Eun Man ; Ha, Jongwon ; Kim, Sang Joon ; Park, Myoung Hee ; Ahn, Curie ; Kim, Yon Su</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Antibodies, Monoclonal, Murine-Derived</topic><topic>Antigens, CD20 - biosynthesis</topic><topic>Biopsy</topic><topic>Female</topic><topic>Graft Rejection</topic><topic>Graft Survival</topic><topic>Histocompatibility Testing - methods</topic><topic>Humans</topic><topic>Immunoglobulins - chemistry</topic><topic>Kidney Transplantation - methods</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Plasmapheresis</topic><topic>Rituximab</topic><topic>Transplantation Conditioning</topic><topic>의학일반</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Sun Moon</creatorcontrib><creatorcontrib>Lee, Chungsik</creatorcontrib><creatorcontrib>Lee, Jung Pyo</creatorcontrib><creatorcontrib>Kim, Eun Man</creatorcontrib><creatorcontrib>Ha, Jongwon</creatorcontrib><creatorcontrib>Kim, Sang Joon</creatorcontrib><creatorcontrib>Park, Myoung Hee</creatorcontrib><creatorcontrib>Ahn, Curie</creatorcontrib><creatorcontrib>Kim, Yon Su</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Journal of Korean medical science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Sun Moon</au><au>Lee, Chungsik</au><au>Lee, Jung Pyo</au><au>Kim, Eun Man</au><au>Ha, Jongwon</au><au>Kim, Sang Joon</au><au>Park, Myoung Hee</au><au>Ahn, Curie</au><au>Kim, Yon Su</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kidney transplantation in sensitized recipients; a single center experience</atitle><jtitle>Journal of Korean medical science</jtitle><addtitle>J Korean Med Sci</addtitle><date>2009-01</date><risdate>2009</risdate><volume>24 Suppl</volume><issue>Suppl 1</issue><spage>S143</spage><epage>S147</epage><pages>S143-S147</pages><issn>1011-8934</issn><eissn>1598-6357</eissn><abstract>A successful transplantation, across a positive crossmatch barrier, is one of the most persistent long-standing problems in the field of kidney transplant medicine. The aim of this study was to describe seven consecutive living renal transplantations in recipients with positive crossmatch for donors or positive for donor specific antibodies (DSAs). A preconditioning regimen including plasmapheresis and intravenous immunoglobulin was delivered three times a week until the crossmatch and/or DSAs became negative. Mycophenolate mofetil and tacrolimus were started two days before the plasmapheresis. The protocol was modified to include administration of anti-CD 20 antibody (rituximab, 375 mg/m(2)) from the patient number 3 through the patient number 7. All seven patients achieved negative conversion of the crossmatch or DSAs, and the kidney transplantations were successfully performed in all cases. Acute cellular rejection occurred in two patients, which were subclinical and controlled with high dose steroid treatment. Antibody-mediated rejection occurred in one patient, which was easily reversed with plasmapheresis. All recipients attained normal graft function during the 7-24 months of follow up. Our study suggests that sensitized patients can be transplanted successfully with desensitization pretreatment.</abstract><cop>Korea (South)</cop><pub>The Korean Academy of Medical Sciences</pub><pmid>19194544</pmid><doi>10.3346/jkms.2009.24.S1.S143</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1011-8934 |
ispartof | Journal of Korean Medical Science, 2009, 24(0), , pp.143-147 |
issn | 1011-8934 1598-6357 |
language | eng |
recordid | cdi_nrf_kci_oai_kci_go_kr_ARTI_574478 |
source | PubMed Central (Open Access) |
subjects | Adult Antibodies, Monoclonal - pharmacology Antibodies, Monoclonal, Murine-Derived Antigens, CD20 - biosynthesis Biopsy Female Graft Rejection Graft Survival Histocompatibility Testing - methods Humans Immunoglobulins - chemistry Kidney Transplantation - methods Male Middle Aged Original Plasmapheresis Rituximab Transplantation Conditioning 의학일반 |
title | Kidney transplantation in sensitized recipients; a single center experience |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T09%3A25%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kidney%20transplantation%20in%20sensitized%20recipients;%20a%20single%20center%20experience&rft.jtitle=Journal%20of%20Korean%20medical%20science&rft.au=Kim,%20Sun%20Moon&rft.date=2009-01&rft.volume=24%20Suppl&rft.issue=Suppl%201&rft.spage=S143&rft.epage=S147&rft.pages=S143-S147&rft.issn=1011-8934&rft.eissn=1598-6357&rft_id=info:doi/10.3346/jkms.2009.24.S1.S143&rft_dat=%3Cproquest_nrf_k%3E66890969%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=66890969&rft_id=info:pmid/19194544&rfr_iscdi=true |